Inc., Kankakee, Ill. TNP-BGG was prepared by the reaction of 2,4,6-trinitrobenzene sulfonic acid (TNBSOs; Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.) in 0.28 M Na cacodylate, pH 7.2, for 1 h at room temperature, followed by extensive dialysis. The concentration of the conjugated protein was determined by dry weight analysis and its degree of derivitization was estimated spectrophotometrically from the absorbance at 348 nm (e for TNP-lysine = 15,400). The TNP-BGG preparation used in these experiments had 24 TNP groups per BGG molecule. Trinitrophenylated-lysine-Fieoll (TNP-F) was prepared by by the reaction of E-TNP-L-lysine HC1 (ICN Nutritional Biochemicals, Cleveland, Ohio) with Ficoll (400,000 mol wt; Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) activated by cyanogen bromide at pH 10.0 for 24 h, followed by extensive dialysis. Trinitrophenylated-polyacrylamide beads (TNP-PAA) were prepared according to the methods of Inman and Dintzis (9) . The aminoethylated polyacrylamide was synthesized by the reaction of ethylenediamine (Sigma Chemical Co., St. Louis, Mo.) with Bio-gel-P30 (Bio-Rad Laboratories, Richmond, Calif.) for 30 min at 90°C. The reaction was terminated by the addition of an equal volume of crushed ice, and the activated gel was washed extensively with 0.1 M NaC1. 1 g of the aminoethylated material in 30 ml of 0.09 M sodium tetraborate, pH 9.3, was reacted with 3 mmol of TNBSOa at room temperature for 24 h. The product was extensively washed with 0.2 M NaC1-Tris base and then with 0.2 M NaCI.
Cell Culture. Primary antibody responses were elicited in culture as described by Mishell and Dutton (10) , using the T-dependent antigen, sheep erythrocytes (SRBC), and the Tindependent antigen TNP-PAA. Spleens were teased in RPMI 1640, passed through sterile gauze to remove clumps, washed twice, and resuspended in culture medium. Cells were cultured at 107 or 5 X 10 s cells per dish in modified minimal essential medium supplemented with 100 U penicillin/ml, 10 #g streptomycin/ml, 2 mM glutamine, 5 × 10 -s M 2-mercaptoethanol, and 10% fetal calf serum (FCS). Cultures were "fed" daily, as described by Mishell and Dutton (10) , and were rocked at 7 oscillations per minute in a humidified atmosphere of 10% CO2, 7% 02, and 83% N2.
Separation of Cells on Antibody-coated Dishes. The basic technique used was that devised by
Mage et al. (11) for selection of surface positive immunoglobulin (SIg +) cells from murine spleen cells. Purified rabbit anti-mouse Ig antibody (RAMIg) was prepared by affinity chromatography of hyperimmune rabbit anti-mouse Ig antiserum on a mouse Ig-sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc.) immunoadsorbent. After purification, the antibody was filtered and stored at 4°C as a 1 mg/ml solution in phosphate-buffered saline (PBS). To coat the plates (100-ram plastic dishes; 8-757; Fisher Scientific Co., Pittsburgh, Pa.) with Ig, 25/xg of this solution was diluted in 10 ml for each plate and incubated overnight at 4°C. Plates were washed with PBS and then incubated for 1 h with 10 ml of PBS and 5% FCS. Plates were again washed, and 40 X 106 spleen cells in 10 ml PBS and 2% FCS was applied to each plate. After 1 h, the nonadherent cells were removed, the plates were washed, and the adherent, SIg + cells were flushed off the plates.
Immunization. Mice were immunized by the intraperitoneal injection of 500/~g TNP-BGG emulsified in (2FA containing 2 mg/ml Mycobacterium butyricum in a final volume of 0.2 ml. In some experiments, animals were immunized with 10/.tg TNP-F i.v. Cell transfer recipients were killed at various times after immunization, and their spleens were assayed for anti-TNP plaqueforming cells (PF (2) .
PFC Assay. Anti-TNP PF(2 were determined by the Dresser and Greaves (12) slide modification of the Jerne plaque assay (13) . TNP-conjugated SRB(2 were prepared by the reaction of TNBSOa with washed SRB(2, as described by Rittenberg and Pratt (14) . Slides were incubated for 1 h at 37°(2. Fresh-frozen guinea pig serum (absorbed with 50% packed SRB(2) was added at a final dilution of 1:30 as a source of complement ((2), and the slides were incubated for an additional 45 min. Detection of indirect anti-TNP plaques was effected by addition of rabbit anti-mouse Ig antiserum at a dilution that had been found to be optimal for plaque development.
Antiserum Treatment. In some experiments, the spleen cell population was depleted ofT cells by treatment (at a concentration of 4-5 × 107 cells/ml) with a 1:45 dilution of a rabbit antimouse brain antiserum (RAMB) and (2. Agarose-absorbed guinea pig serum (1:12 dilution) was used as the (2 source. The (2 had been shown to be nontoxic for mouse cells. The cells were incubated with antiserum plus (2 for 30 min at 37°(3 and were then washed three times. The RAMB was prepared by the method of Golub (15) and was absorbed with agarose, mouse bone marrow cells, and mouse kidney powder. The absorbed antiserum killed >95% of mouse thymus cells, <5% of mouse bone marrow cells, and ~40% of mouse spleen cells. It prevented mouse spleen cells from producing an in vitro proliferative response to phytohemagglutinin.
Results

Suppression of the Response to TNP-BGG by Spleen Cells from Mice Immunized with TNP-BGG in CFA.
Mice were immunized with 500/.tg TNP-BGG in CFA. These will be referred to as immune mice. Lethally irradiated mice were reconstituted with normal spleen cells, with immune spleen cells (obtained 1 wk after immunization), or with a mixture of normal and immune spleen cells. Recipients were immunized 1 d after cell transfer with 500 #g TNP-BGG in CFA. Animals were assayed for anti-TNP PFC at 2 or 3 wk after cell transfer. The results are presented in Table I . Mice reconstituted with immune spleen cells gave a secondary response, characterized by a greater number of indirect PFC, an increased ratio of indirect/direct PFC, and an earlier peaking of the response as compared with mice reconstituted with naive spleen cells (compare assays done at 2 and 3 wk, experiment 2, Table I ). However, when mixtures of normal and immune cells were transferred, the PFC response was markedly more depressed than was expected. This was especially pronounced at 2 wk after cell transfer. It should be noted that in all cases the response of the recipient of a mixture of normal and immune cells was markedly lower than that of recipients of immune cells alone, and in some cases it was even lower than the response of animals receiving only naive cells. Generally, both direct and indirect PFC responses were depressed in animals reconstituted with a mixture of normal and immune cells.
It should be mentioned that the peak of the primary PFC response of normal LAF1 mice to TNP-BGG in CFA has been previously shown (16) to occur 7-9 d after immunization. In the present studies, immune spleens were assayed for suppressor activity in mixed cell transfer experiments at 1, 2, and 3 wk after immunization. Suppressor activity was greatest at 1 wk after immunization (Table I) , was decreased at 2 wk after immunization (Table II , experiment 1), and was not detectable at 3 wk after immunization (Table II, Table III . In each experiment, mice reconstituted with TNP-BGG immune spleen cells gave a markedly lower response to the T-independent antigen TNP-F than did animals reconstituted with naive spleen cells. Mice reconstituted with mixtures of normal and immune spleen cells gave anti-TNP responses to TNP-F that were depressed by 38-67% as compared with those of mice reconstituted with only normal spleen cells. In experiment 3, immune spleen cells were treated with RAMB plus C before transfer. This treatment did not affect the response of the immune cells. The response of mice reconstituted with normal plus RAMB-treated immune spleen cells was still suppressed (Table III) .
To rule out the possibility that the peak response of the immune population was missed by assaying only at day 7, a transfer was performed in which groups were assayed daily from 3-7 d after antigen injection. There was no difference in the magnitude of the PFC response of mice reconstituted with immune spleen cells from 4-7 d after immunization. On day 3 the response was considerably lower. The response of mice reconstituted with cells from normal donors peaked at 6-7 d after immunization, and suppression was most pronounced when assayed at this time (data not shown). Essentially, no indirect plaques were detected in the response to TNP-F under the conditions of these experiments.
To be certain that the suppressive activity was not the result of exposure to CFA, donors were immunized with TNP-BGG in CFA or CFA alone before transfer (experiment 2, Table III ). The response by mice reconstituted with spleen cells from animals preimmunized with CFA alone is equivalent to the response of mice reconstituted with normal spleen cells. Mixing cells from mice preimmunized with CFA with cells from naive mice does not result in suppression of the response as compared with that of mice reconstituted only with cells from normal donors.
Suppression of the In Vitro Anti-TNP PFC Response by Immune Spleen Cells. Spleen cells
from normal mice or from mice immunized 1 wk previously with TNP-BGG in CFA were challenged in vitro with SRBC or with the T-independent antigen TNP-PAA. A representative experiment is presented in Table IV . Spleen cells from immune mice produce far fewer PFC in response to TNP-PAA than do spleen cells from normal mice. Although the anti-SRBC response of immune spleen cells is somewhat lower than that of normal spleen cells in this experiment, the response is still within the usual range of these cultures (Table V) . When 5 × 106 spleen cells from immune mice were mixed with 5 × 10 s cells from normal mice, the anti-TNP-PAA response was suppressed 91%. The suppressive activity was TNP specific in that there was no suppression of the anti-SRBC response (Tables IV and V) . Even 1 × 106 spleen cells from immune mice caused marked suppression of the response of 5 X 106 normal spleen cells (Table IV) . Experiments were carried out to characterize the nature of the suppressive activity (Table V) . Spleen cells from either the immune or normal mice, or both, were treated with RAMB antiserum and C. All controls were treated with C alone. The anti-TNP-PAA responses of mixtures of normal and immune spleen were suppressed 70-90%, calculated on the basis of simultaneous cultures of the individual cell populations comprising the mixtures. RAMB antiserum and C treatment of the immune spleen cell population did not alter the suppression. When the normal spleen cell population was treated with RAMB antiserum plus C and mixed with immune spleen cells, the degree of suppression was significantly decreased, although it was not eliminated. However, when RAMB plus C-treated immune cells were mixed with RAMB plus Ctreated normal cells, the anti-TNP response was markedly suppressed.
Comparable results were obtained when anti-Thy-1 was used instead of RAMB antiserum. For example, in some experiments the immune spleen cells were treated with a monoclonal anti-Thy-l.2 and C instead of the RAMB. The cells remaining after treatment were possibly enriched for suppressive activity (Table IV) . Certainly, suppression was not eliminated by anti-Thy-1.2 treatment of the immune cell population. Because it has been reported (17) that in certain systems, specific suppressor T cells may be resistant to anti-theta antiserum and C treatment, other purification steps were taken to analyze the nature of the suppressive activity. SIg + cells were positively selected from the immune spleen cell population by panning on plastic dishes coated with RAMIg (Table VI) . It was found that the SIg ÷ cells were enriched for suppressive activity compared with unseparated immune spleen cells. The RAMIg adherent spleen cells were then treated with anti-Ly-1,2 and C to eliminate any remaining T cells. These cells still suppressed the normal response (Table VI) .
Suppression of the In Vitro Anti-TNP PFC Response by Supernate from Immune Spleen Cells.
The following experiment was done to test whether a soluble suppressive substance was generated by the immune spleen cells. 7 d after immunization with 500 #g TNP-BGG in CFA, spleen cells were put into culture without antigen. After 24 h, the cultures were centrifuged and the supernate passed through a Millipore membrane. This immune supernate was compared with the effect of supernates obtained simultaneously from cultures of spleen cells from unimmunized cells. At a concentration of 50% (~4 × 106 cell equivalents) the immune S/N suppressed the anti-TNP response of normal spleen cells (control response) by -50% (Table VII) . Control S/N had either no effect or an enhancing effect on the control response.
Discussion
The results presented here demonstrate the development of specific suppressive activity during the course of an immune response to TNP-BGG. This activity was effective in depressing the in vivo response to TNP on both T-dependent and Tindependent carriers. When TNP-BGG immune spleen cells were transferred to an irradiated mouse and challenged with TNP-BGG, they produced a characteristic secondary response. Suppression was only evident when mixtures of normal and immune spleen cells were challenged, suggesting that induction of suppressive activity in the normal spleen cells might be taking place. However, when mice reconstituted with TNP-BGG immune spleen cells were challenged with TNP-F, the magnitude of The difference between these two sets of experiments lies in the challenge antigen. In the first group, it is probable that sufficient carrier (BGG)-specifie help was present to overcome the effects of the suppressive activity, and a secondary response was obtained. When a T-independent carrier (Ficoll) was used for challenge, the carrierspecific help was not operative, and the response of both the immune cells alone and the mixture of immune and normal cells was suppressed. Comparable results were also obtained in vitro studies.
We believe that the cell responsible for suppression is a B cell because (a) immune cells treated with RAMB and C suppressed both the in vivo anti-TNP-F response and the in vitro TNP-PAA response, and (b) SIg plus cells obtained from the immune population by elution from plastic dishes coated with RAMIg were enriched for suppressive activity, and further treatment of these cells with anti-Ly-1 and anti-Ly-2, and C did not affect their suppressive activity. Because this population is relatively depleted of macrophages and the suppression observed was antigen specific, it is unlikely that macrophages are responsible for the suppression. However, we have not formally ruled out a role of the macrophages that could possibly passively carry the suppressive activity. Although the initial experiments were performed using an RAMB antiserum, treatment of immune spleen with a monoclonal anti-theta or positive selection on anti-Ig-coated plates followed by treatment with anti-Ly-1,2 and C also failed to eliminate the suppressive activity, which confirmed that it was not a T cell.
The mechanism of suppression has not been characterized. Two possibilities exist. One is classical antibody feedback, that is, the production of anti-TNP antibody by the B cells, which could bind antigen and block its interaction with specific cells. The other possibility is anti-idiotypic antibody induced by the receptors of the immune B cells. The anti-idiotype antibody might bind the receptors of the assay B cells and inhibit antibody secretion. Precedents exist in the literature for both mechanisms (1, 2, 18) . A soluble specific suppressor factor was detected in the supernate from immune spleen cells cultured in the absence of antigen. However, the suppressor factor was not further characterized. It is unlikely that the immune spleen contains a highly suppressive antigen fraction because such "processed" antigen would usually be regarded as immunogenic. It would have to exert differential effects on normal and immune cells because treatment of normal spleen cells with RAMB decreased suppression when immune T cells were present. Furthermore, the activity of the soluble suppressor factor was removed by incubation with antigen.
Recently, Zubler et al. (19) have demonstrated that surface Ig-bearing, Ly-l-2-3-, B lymphocytes, after incubation in vitro with SRBC, could exert potent specific suppressive effects on primary in vitro responses. There are many similarities between their system and the one studied here. However, it must be stressed that we have shown that this regulatory mechanism operates in vivo as well as in vitro. That this mechanism can operate in vivo emphasizes its possible importance in the normal regulation of the immune response.
Characterization of the requirements for demonstration of suppressive activity in vitro suggests that its occurrence may be dependent upon complex interactions among different cell populations. Removal of T cells from the immune spleen by incubation with RAMB antiserum and C did not decrease suppression. In contrast, removing T cells from the normal spleen cell population markedly reduced the suppressor activity, suggesting that an interaction between immune spleen cells and normal T cells is involved in generating suppressor activity. However, when T cells were eliminated from both immune and normal spleen cell preparations, the mixture generated marked suppressor activity. This clearly indicates that although T cells may be involved in regulating the degree of suppression, they are not necessary for the generation or manifestation of suppressor activity in this system.
The role of the T cell in this system is interesting. It appears that the T cells in the normal spleen cell population augment the suppression (i.e., their depletion decreases suppression), whereas T cells in the immune spleen cell population decrease the suppression (i.e., their deletion, when T cells have also been deleted from the normal spleen cell population, increases suppression). Thus, the T cell population in the immune spleen acts as an antagonist of suppression. We would suggest the term "abrosuppressor" to refer to this T cell-mediated antagonism of suppression. The abrosuppressor does not appear to be a traditional helper T cell because it prevents the suppression of the response to a highly T-independent antigen (TNP-PAA). The term "contrasuppressor" has recently been proposed (20) to describe a nonspecific activity generated upon culture of normal neonatal mouse spleen cells, which reversed the nonspecific suppressor activity generated upon culture of adult spleen cells. It was suggested that the contrasuppressor acted by rendering the helper T cell less responsive to suppression. The contrasuppressor appears to be distinct from what we are referring to as an abrosuppressor in that the latter activity is specific rather than nonspecific, and because it affects the responses to a T-independent antigen, it does not appear to act via an effect on helper T cells.
The nature of the interaction between immune and normal spleen cell populations, which leads to the development of specific suppressor activity, is not obvious. It is possible that T cells in the normal spleen cell population interact with the antigenspecific immune spleen cells to generate idiotype-specific suppressor T cells (21) . It is known that Ig-associated structures on activated B cells can trigger Ly-1+2 -inducer cells to stimulate Ly-2 ÷ T suppressor activity (22) . Mechanisms such as these could explain how the removal of T cells from the normal spleen cell population can decrease suppression. It seems likely from much of the current literature in immunology that suppression is dominant in the naive state of the immune system. That is, the immune system normally exists in a suppressed, stable, steady state. In part, the stability of this suppressed state appears to be the result of a network of interactions involving idiotypes and anti-idiotypes as suggested by .Jerne, and in part this suppressed stable state appears to result from a constant level of suppressor T cell activity. On the basis of this line of reasoning, we would propose the hypothesis that the initiation of an immune response involves temporarily abrogating this chronic state of suppression. The results reported here suggest that specific abrosuppressor cells can be stimulated by antigen and can act to block suppressor cell activity. It is suggested that the stimulation of specific abrosuppressor activity may be essential for the induction of an immune response to take place; in its absence suppression would remain dominant and no immune response would occur.
SummaFy
The ability of lymphoid cells from immunized animals to regulate the response of naive B ceils to the immunizing hapten was studied. Mice were immunized with trinitrophenylated (TNP) bovine gamma globulin (BGG) in complete Freund's adjuvant, and their spleen cells were examined in vivo and in vitro for the presence of specific inhibitory activity. This activity was found to peak 1 wk after immunization, was active against TNP on both T-dependent (BGG) and T-independent (Ficoll and polyacrylamide beads) carriers, and was demonstrable both by mixed cell transfers and mixed cell culture experiments. In in vitro studies, it was shown that the inhibition of the response to TNP-polyacrylamide beads by immune spleen cells was mediated by a non-T cell, possibly a B cell, because the suppressor activity was enriched in a purified B cell preparation. A role for macrophages was not formally ruled out. A specific suppressor factor was produced in vitro by immune spleen cells cultured in the absence of antigen. The suppressor activity was modulated by T .cells because elimination of T cells from the normal spleen cell population decreased suppression; elimination of T cells from the immune spleen cell population did not effect suppression, but elimination of T cells from both the normal and immune spleen cell populations allowed the expression of marked specific suppression. Thus, T cells present in the normal spleen cell population augment the degree of suppression, whereas T cells present in the immune spleen cell population decrease the degree of suppression; that is, T cells present in the immune spleen cell population had the ability to specifically abrogate suppression ("abrosuppression") in a T-independent immune response. It is proposed that the response to a T-independent antigen is regulated by specific suppressor activity generated by a non-T cell and augmented by the interaction of this cell with a T cell. The suppressor activity can be blocked by a specific abrosuppressor T cell. It is suggested that, because suppressor activity appears
